Glucose Metabolism Disorders  >>  AMG 151  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 151 / Amgen
NCT00859755: A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

Completed
1
41
US
ARRY-403, glucokinase activator; oral, Placebo; oral
Array BioPharma
Type 2 Diabetes
07/09
 
NCT01755442: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

Terminated
1
5
US
Placebo, AMG 151
Amgen
Diabetes Mellitus
01/13
01/13

Download Options